Ligand Pharmaceuticals (LGND) Gross Profit Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.16% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.34% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 51.16% |
| 10 | Ligand Pharmaceuticals | 4.55 Bn | 3.77 Bn | 48.45 Mn | 6.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.36% |
| Dec 31, 2025 | 25.36% |
| Sep 30, 2025 | 35.31% |
| Jun 30, 2025 | 5.80% |
| Mar 31, 2025 | 8.36% |
| Dec 31, 2024 | -3.45% |
| Sep 30, 2024 | 0.76% |
| Jun 30, 2024 | -7.16% |
| Mar 31, 2024 | -9.92% |
| Dec 31, 2023 | -23.13% |
| Sep 30, 2023 | -6.10% |
| Jun 30, 2023 | -9.91% |
| Mar 31, 2023 | 12.24% |
| Dec 31, 2022 | 4.70% |
| Sep 30, 2022 | 27.66% |
| Jun 30, 2022 | 18.70% |
| Mar 31, 2022 | -7.05% |
| Dec 31, 2021 | -7.78% |
| Sep 30, 2021 | 2.96% |
| Jun 30, 2021 | -18.43% |
| Mar 31, 2021 | -11.45% |
| Dec 31, 2020 | 0.23% |
| Sep 30, 2020 | -6.39% |
| Jun 30, 2020 | -27.64% |
| Mar 31, 2020 | -20.09% |
| Dec 31, 2019 | -10.78% |
| Sep 30, 2019 | 1.66% |
| Jun 30, 2019 | 6.30% |
| Mar 31, 2019 | 11.36% |
| Dec 31, 2018 | 40.76% |
| Sep 30, 2018 | 39.02% |
| Jun 30, 2018 | 77.80% |
| Mar 31, 2018 | 59.96% |
| Dec 31, 2017 | 44.95% |
| Sep 30, 2017 | 47.53% |
| Jun 30, 2017 | 111.50% |
| Mar 31, 2017 | 60.47% |
| Dec 31, 2016 | 38.02% |
| Sep 30, 2016 | 25.36% |
| Jun 30, 2016 | 30.98% |
| Mar 31, 2016 | 37.71% |
| Dec 31, 2015 | 21.56% |
| Sep 30, 2015 | 42.44% |
| Jun 30, 2015 | 43.91% |
| Mar 31, 2015 | 35.14% |
| Dec 31, 2014 | 20.42% |
| Sep 30, 2014 | 38.82% |
| Jun 30, 2014 | 17.29% |
| Mar 31, 2014 | 58.83% |